The number of people with diabetes in America has been on the upswing in recent years, and so has the number of amputations related to complications from the illness. As with many other health care ...

Diabetes-related amputations have reversed a decade-long trend and are now on the rise, according to the American Diabetes Association (ADA). ADA’s Amputation Prevention Alliance reports that 154,000 ...

Diabetes is a chronic condition that affects millions of people worldwide. It primarily impacts how your body turns food into energy, often leading to elevated blood sugar levels. While managing ...

Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are ...

When Derek from Indiana first noticed problems with his toes, he followed his doctor’s advice without question – amputation. Diabetes, they told him, was the culprit. One by one, his toes were ...

Diabetes is a chronic condition affecting millions of people worldwide, leading to numerous health complications if not properly managed. One seemingly minor aspect of diabetic care often overlooked ...

Lower extremity amputation remains one of the most serious complications of diabetes, reflecting the combined effects of peripheral neuropathy, vascular disease and recurrent foot ulceration.

More than three decades after a diagnosis of Type 2 diabetes, Michelle Caldwell says her disease is better controlled than ever. She keeps regular appointments with her endocrinologist, primary care ...

Disparities in rates of peripheral diabetic neuropathy and lower extremity amputation exist in the United States. To investigate the factors linked to this disparity, we performed a systematic review ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

The latest New York City public health campaign was so determined to make it very clear that diabetes leads to amputation that it created a fictional amputee. New York City's health department ...

(Reuters) - Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration said on Tuesday. Final ...